Utilization of Immunization Information Systems (IIS) among independently owned community pharmacies: A national survey

Immunization information systems (IIS) consolidate provider-submitted immunization information. We reassessed independently owned community pharmacies’ IIS enrollment, verification of immunizations needs via IIS records retrieval, and immunization records reporting to IISs following post-pandemic sh...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2024-01, Vol.42 (2), p.65-68
Hauptverfasser: Meininger, Christopher, Ezeala, Oluchukwu, McCormick, Nicholas, Fish, Hannah, Beckner, John, Ha, David, Westrick, Salisa C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Immunization information systems (IIS) consolidate provider-submitted immunization information. We reassessed independently owned community pharmacies’ IIS enrollment, verification of immunizations needs via IIS records retrieval, and immunization records reporting to IISs following post-pandemic shifts in community pharmacy operations. A cross-sectional online survey of National Community Pharmacists Association pharmacist, pharmacy owner, and pharmacy technician members was conducted in Fall 2022. 202 complete responses were analyzed. Margin of error was an estimated 7 %. Respondents were: 53.2 % female, ∼87 % White, 69.8 % managers, and 86.1 % practicing in standalone community pharmacies. Almost all (91.6 %) were enrolled in IIS. About two-thirds frequently or always utilized IIS to retrieve immunization records prior to immunization. On average, 81.2 % of influenza and 83.5 % of non-COVID/non-influenza vaccination records were submitted. Enrollment rates are high among studied pharmacies, as are records reporting rates. However, records retrieval rates are suboptimal. Future work should focus on addressing suboptimal retrieval rates within immunization-providing pharmacies.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2023.12.040